Polpharma Biologics – Building on early achievements

Published: 27.06.2019

In the latest issue of Pharma’s Almanac, Guenter Stempfer (Managing Director Duchnice & Board Member) describes Polpharma’s Biologics expansion plans.
Read more about the company growth strategy and constructing of the second manufacturing facility in Duchnice, near Warsaw.
Learn about the new investment and how Polpharma Biologics will provide customers with large-scale manufacturing of drug substance and drug product.

"Polpharma Biologics provides truly integrated contract development and manufacturing services for both branded and biosimilar projects."

written by: Polpharma Biologics

Let’s collaborate and create quality biologics together.

Get in touch for more information.

We use cookies

Polpharma Biologics uses cookies and other similar technologies (hereinafter: cookies) on its webpages and mobile applications (hereinafter, jointly, Website). The user can manage cookies independently by changing the web browser settings. If you do not consent for your personal data to be collected via cookies, you should change your web browser settings or stop using the Website.

Using the Website without changing the web browser settings indicates your acceptance of the use of cookies by Polpharma. Acceptance of the web browser settings indicates your consent to profiling on the basis of the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect lawfulness of any processing activities carried out under consent before its withdrawal.

For more details see the Cookie Policy.